. >> well, amgen tour announced this year's route. >> the race will be between may 11 and may 18. starting in sacramento and ending ending in san jose. >> it starts in east san jose, going up ask over mount hamilton for the finish. here is a live picture of mount diablo tonight >> thanks for joining us. i'm cheryl jennings >> we appreciatit your >>> welcome to "world news." tonight -- powder keg on fire. deadly violence erupts in ukraine again. wounded carried through the streets. the abc team sees bullets flying through their windows. will america be forced to take action tonight? >>> wild weather. tonight, 17 states standing watch on the latest storm, including floods and tornadoes. as we're all battling potholes half the size of your car. >>> last laugh. once this man could not get a job at facebook, and now facebook has paid him so much money he's a billionaire. sweet revenge. >>> and secret language. will this test prove tonight that your dog is really thinking and feeling exactly the same thing you are?

also, amgen, up about 7% this month alone.na on the insurance side of things, up about 3% in today's trade. back to you. >> thank you very much, dom. >>> used cars, pilots and phil lebeau. the high tech way thieves are breaking into and stealing cars in chicago. phil? >> reporter: thanks for lumping me in with the thieves. let's talk about this new way we are seeing people steal cars. this video is something else. take a look at this surveillance cam video. you see somebody going up to a car that is parked there. they have something in their hand and then they can open the door. they are not smashing the window. chicago police are looking into what exactly is this mysterious black box that allows a thief to in this case get inside the car, take whatever's on the inside. we do know that not only in chicago but around the country, police are looking into what this black box is all about that allows them to override the car computers. let's move on to auto sales. cold weather all month. we thought it was going to ease up in the s

test its immuno-oncology drug mk3475 in commibation with medications under development by pfizer, amgen and incyte. also on wednesday, merck reported sales numbers that were slightly lower than expect as it faces competition from generic drug makers. boeing is speeding up production of a popular jet. the company will manufacture its 7- 3-7 at a faster pace. boeing says it's able to get the planes made quicker through improvements in efficiency. it comes on the heels of record earnings from the jet maker. the company set a lofty goal of topping delivery records set in 20-13. boeing is among several large corporations that have recently dealt with tough union negotiations...in a speech to the uaw wednesday. vice president joe biden rallied union members.. as union membership dropped and declined, the share of income earned by americans in the middle class began to decrease. guys, it's not an exaggeration; the national labor relation board-- is trying again to speed up the process of signing on union members. the n-l-r-b contends current rules provide too many opportunities for employers t

we're talking about names biogen, gilae a d, amgen. what you're looking at is a lot of optimism that has crept into the space because of a lot of notable stories. people want to be long on that call action. i am absolutely with carter. this thing is extended. >> what are you doing to protect yourself. >> because this is an index, you don't have to pay as much. i'm going to go out and buy specifically the june 240 puts. you'll pay $15 for those. i think this goes lower. >> is that an expensive put? >> it is. implied volatility in this name is close to the 52-week high. i would ask if i were at home, i would ask why not do a spread. mike explains why. he wants to spread out of it. that said, we like to do that. in this situation there's not a whole lot of room for error. if this doesn't work out, you're not going to get a chance to spread out profit. >> a good thing about doing a spread, that is something you consider, sell 2920s, the 200s against it, betting against that, use limit orders. the spreads on these options are a little bit w

that they are investing so much money down there, there is something to worry, people like paulson, amgenor ge or j&j or general electric, what they are doing, why they are expanding their presence in puerto rico, it is just an example of why it is really happening down there. and doesn't invest there, it shows the world but that is the place to go right now. that you have to take a look at puerto rico in a more conference of way to see the opportunities that the world can have down there in puerto rico. as part of the united states offered to the world. >> for more of bloomberg's coverage of puerto rico's economic woes, you can go online at bloomberg.com/tv, or visit our award-winning ipad app, btv+ . there is no mountain high enough for this ceo. we will discuss his business coming up next. and a donor prince of wall street. we will introduce you coming up. ♪ >> this is "lunch money," on bloomberg television, and we are streaming live on bloomberg.com, your tablet, and your phone. we are everywhere you are. i am adam johnson. we kick off our new biweekly series of small to big. about ce

first immunotherapy on the market, used for malignant mel known gno melanoma and leading companies, amgen all working in this field. novartis. interesting is, nobt only are they showing dramatic benefits basically in allowing to take the patient's own immune system and turn it against cancer cells and fight them, but they're also being studied in combination with existing chemotherapy putic acts. so continuing to move cancer towards a sdheez cdisease that cured or patients maintained and healthy for sustained periods of time. tremendous amount of positive success and data as you're talking about, and a lot of money being invested behind this, and very, very exciting for both the companies and certainly the patients. >> in terms of the large pharma companies, barbara the once you mentioned, bristol meyers and merck specifically, are there smaller ones? investing on their own? seems the smaller biotech companies are working on this as well and might be potential takeover companies for the big guys? >> at this point it takes a village and there are collaborations going on with all of those c

remember in the 1970s, i'm old enough to remember back then, microsoft, apple, amgen, fedex and otherpanies were tiny babies then and became the giants that they are today so you're always getting that kind of shift, but what's remarkable about this recovery is we haven't had a sharp upturn. we saw in the 1970s a terrible decade, but after we got things straightened out in the early '80s, by goal the economy took off. this so you get a sharp downturn and you always get a sharp upturn, and we're not getting that this time. and the fed reserve has been practicing trickle down economics. they messed up the credit markets which hurt credit accession for small and new businesses which are the job creators and try to prop up the stock market which guess what, helps upper income people and yet the democrats gave a bye to ben bernanke and put in janet yellen as a successor to ben bernanke practicing a policy that hurt credit markets and job creators, the new businesses. >> austan, it is true, is it not -- main street, i'm sorry, if you ask the general public are we headed in the right directi

this guy here just bought a german drug distribution company -- >> is that amgen? >> it is not. this one here is a merger back in 2001, two names coming together. check this out. this is mckesson, and this one here, amerisource bergen. a stock picker's market means that you can make a difference in picking the right stocks in an overall -- >> i think if you had given me a letter or two, i might have gotten it. >> or maybe a ticker. >> maybe. dom, thank you very much. >>> ali mcgraw said it best when she told ryan o'neill that love means never have to say i'm sorry. for some wall street analysts, love means never having to say the word downgrade. will that leave investors brokenhearted? let's ask sheilla dharmarajan. >> it is all about love, love, love today. we wanted to do a little business spin on this whole love theme and found a couple stocks that are getting a whole lot of analysts' love. in honor of that, the guys at the nasdaq actually gave me this pink heart. let's get talking about the stocks. the first up is allegian. it makes security products for homes and businesses

quarter ruls came in better than expected and guidance was solid and biotech mixed action, and look at amgens social media. take a look at facebook, linkedn, groupon, they are up a percent today, but you got to talk about tesla, that's the big one everyone is waiting for, they hit a regard butted to we're trading lower ahead of the earnings and, of course, ahead of what mr. elon musk is going to say himself. >> all right, sheila, thank you very much. >>> let's shift to bloonds and e dollar. rick santelli at the cme. hey, rick. >> we'll get to the dollar. i don't know if what a year is the word i would describe. what a boring year is way i would describe it. let us start with interest rates, the slippage of rates in 2014 there was a bounce, of course, when the equity markets righted themselves but it is having an impact on the curve. the two-year note its yield even though it moves in much smaller increments because eyes only 29 basis points, this is the lowest yield closes since early december. let's move down the curve and five year, if five year was to close it would be the lowest yield cl

merck announced a partnership with insight amgen and pfizer. it comes to biotech. the world health organization says the cancer cases are going to be up 57% by 2020. those kind of trends, as sad as it is, actually farewell for a company like merck. >> when you said magic words i thought they were i don't guess go tee trough earnings for 2014. >> nice catalyst. if they're forecasting things are going to get better, that's nice. >> estee lauder, perhaps we shouldn't be so concerned. >> maybe we were tempered. but still, this talks about a consumer that may be slowing down. the company came out and said that they expect this coming year to have slowdowns in the u.s. as well as certain asian markets. that's key. korea, china, hong kong, and certain specific markets in europe. so as you look at estee lauder shares, it tells you something about that consumer. this i guess you could call it a staples product for some people. they do use makeup on a more daily basis. maybe not as high end. >> including yourself, dom. >> maybe not as high end as the est